Current status: 949 hESC lines, 5240 hiPSC lines, and 128 clinical studies, and 1885 certificates
Monthly statistic from Nov 1, 2023
Posted on November 1, 2023
| total lines | 6189 |
| hESC lines | 949 |
| hiPSC lines | 5240 |
| derivation countries | 46 |
| projects | 281 |
| providers | 856 |
| clinical studies | 128 |
| subclones | 2402 |
| certificates | 1885 |
| cell line certificates | 1741 |
| project certificates | 144 |